Form 8-K - Current report:
SEC Accession No. 0001999371-25-002252
Filing Date
2025-03-04
Accepted
2025-03-04 07:05:40
Documents
50
Period of Report
2025-03-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_030425.htm   iXBRL 8-K 29806
2 PRESS RELEASE OF THE COMPANY, MARCH 4, 2025 ex99-01.htm EX-99.01 36016
3 TARGET NON-RESTORATIVE SLEEP SHOWED DURABLE PAIN REDUCTION IN TWO DOUBLE-BLIND R ex99-02.htm EX-99.02 53348
7 GRAPHIC ex99-02_img001.jpg GRAPHIC 198133
8 GRAPHIC ex99-02_img002.jpg GRAPHIC 255028
9 GRAPHIC ex99-02_img003.jpg GRAPHIC 179111
10 GRAPHIC ex99-02_img004.jpg GRAPHIC 172460
11 GRAPHIC ex99-02_img005.jpg GRAPHIC 206053
12 GRAPHIC ex99-02_img006.jpg GRAPHIC 169024
13 GRAPHIC ex99-02_img007.jpg GRAPHIC 201687
14 GRAPHIC ex99-02_img008.jpg GRAPHIC 172258
15 GRAPHIC ex99-02_img009.jpg GRAPHIC 156704
16 GRAPHIC ex99-02_img010.jpg GRAPHIC 144656
17 GRAPHIC ex99-02_img011.jpg GRAPHIC 156570
18 GRAPHIC ex99-02_img012.jpg GRAPHIC 150827
19 GRAPHIC ex99-02_img013.jpg GRAPHIC 178095
20 GRAPHIC ex99-02_img014.jpg GRAPHIC 158201
21 GRAPHIC ex99-02_img015.jpg GRAPHIC 151165
22 GRAPHIC ex99-02_img016.jpg GRAPHIC 164006
23 GRAPHIC ex99-02_img017.jpg GRAPHIC 143135
24 GRAPHIC ex99-02_img018.jpg GRAPHIC 115907
25 GRAPHIC ex99-02_img019.jpg GRAPHIC 200990
26 GRAPHIC ex99-02_img020.jpg GRAPHIC 137142
27 GRAPHIC ex99-02_img021.jpg GRAPHIC 162410
28 GRAPHIC ex99-02_img022.jpg GRAPHIC 192887
29 GRAPHIC ex99-02_img023.jpg GRAPHIC 197413
30 GRAPHIC ex99-02_img024.jpg GRAPHIC 197437
31 GRAPHIC ex99-02_img025.jpg GRAPHIC 161454
32 GRAPHIC ex99-02_img026.jpg GRAPHIC 129985
33 GRAPHIC ex99-02_img027.jpg GRAPHIC 188280
34 GRAPHIC ex99-02_img028.jpg GRAPHIC 149976
35 GRAPHIC ex99-02_img029.jpg GRAPHIC 196385
36 GRAPHIC ex99-02_img030.jpg GRAPHIC 177302
37 GRAPHIC ex99-02_img031.jpg GRAPHIC 213562
38 GRAPHIC ex99-02_img032.jpg GRAPHIC 209328
39 GRAPHIC ex99-02_img033.jpg GRAPHIC 179772
40 GRAPHIC ex99-02_img034.jpg GRAPHIC 185828
41 GRAPHIC ex99-02_img035.jpg GRAPHIC 147702
  Complete submission text file 0001999371-25-002252.txt   8728052

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE tnxp-20250303.xsd EX-101.SCH 3024
5 XBRL LABEL FILE tnxp-20250303_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE tnxp-20250303_pre.xml EX-101.PRE 22365
52 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_030425_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 25701502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)